Weight Loss Insights
Losing weight often comes with the risk of losing muscle, bone, and connective tissue, which can weaken the body and increase injury risk. Recent trials show that a significant portion of weight loss from GLP-1 agonists can come from these vital tissues, contrasting sharply with the targeted fat loss seen in trained athletes. Proper training and dieting can lead to fat loss without sacrificing lean mass, highlighting the importance of a scientific approach to weight management.In this clip
From this podcast
The Joe Rogan Experience
Joe Rogan Experience #1934 - Lex Fridman
Related Questions
What are the risks of Ozempic and other semaglutides, and do they encourage muscle loss over fat loss as discussed in the episode 271: Weight Loss Medications + Obesity and the clip Controversial Diabetes Drugs?
What are the risks of Ozempic and other semaglutides, and do they encourage muscle loss over fat loss?
Why is muscle loss a concern when using GLP-1 agonists in the context of the episode #351: Nutrition, Lifestyle, and Longevity: A Heart Surgeon's Perspective with Dr. Philip Ovadia and the clip Weight Loss Medications?